ObsEva's IPO

ObsEva raised a round of funding on January 26, 2017. Investors include Public.

ObsEva is a Swiss-based, speciality biopharmaceutical company dedicated to the development of drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor.…

Articles about ObsEva's IPO: